Detalles de la búsqueda
1.
MIMESIS: minimal DNA-methylation signatures to quantify and classify tumor signals in tissue and cell-free DNA samples.
Brief Bioinform
; 24(2)2023 03 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36653909
2.
Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG).
Lancet Oncol
; 22(7): e327-e340, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34000244
3.
Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial.
Breast Cancer Res
; 23(1): 38, 2021 03 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33761970
4.
Systemic therapy for early breast cancer in older adults: current status and prospects.
Curr Opin Oncol
; 33(6): 574-583, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34183493
5.
Precision Oncology via NMR-Based Metabolomics: A Review on Breast Cancer.
Int J Mol Sci
; 22(9)2021 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33925233
6.
EFFECT: a randomized phase II study of efficacy and impact on function of two doses of nab-paclitaxel as first-line treatment in older women with advanced breast cancer.
Breast Cancer Res
; 22(1): 83, 2020 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32758299
7.
Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.
Br J Cancer
; 122(7): 1119, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31949268
8.
Endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: extending endocrine sensitivity.
Future Oncol
; 16(5): 129-145, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31849236
9.
Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b-2 trial.
Lancet Oncol
; 20(3): 371-382, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30765258
10.
Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial.
Breast Cancer Res
; 21(1): 71, 2019 05 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31142370
11.
Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.
Br J Cancer
; 120(10): 959-967, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30967649
12.
Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE.
Oncologist
; 24(6): e232-e240, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30413667
13.
Early triple negative breast cancer: Are we getting better outcomes? A retrospective analysis from a single institution.
Breast J
; 25(6): 1225-1229, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31310384
14.
A gene expression signature of Retinoblastoma loss-of-function predicts resistance to neoadjuvant chemotherapy in ER-positive/HER2-positive breast cancer patients.
Breast Cancer Res Treat
; 170(2): 329-341, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29564743
15.
An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project.
BMC Cancer
; 18(1): 932, 2018 Sep 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-30261866
16.
Continued value of adjuvant anthracyclines as treatment for early breast cancer.
Lancet Oncol
; 16(7): e362-9, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26149888
17.
Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd Trial.
JCO Precis Oncol
; 8: e2300285, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38427931
18.
EUSOMA quality indicators for non-metastatic breast cancer: An update.
Eur J Cancer
; 198: 113500, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38199146
19.
Breast cancer in the elderly: which lessons have we learned?
Future Oncol
; 9(12): 1871-81, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24295417
20.
Aluminium recovery from waste incineration bottom ash, and its oxidation level.
Waste Manag Res
; 31(9): 954-9, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23831779